Credit Suisse’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,500
Closed -$2.69M 3964
2021
Q4
$2.69M Hold
7,500
﹤0.01% 2547
2021
Q3
$2.48M Buy
7,500
+2,100
+39% +$705K ﹤0.01% 2657
2021
Q2
$1.66M Buy
+5,400
New +$1.51M ﹤0.01% 3011
2021
Q1
Sell
-61,200
Closed -$16.7M 4428
2020
Q4
$16.7M Sell
61,200
-4,200
-6% -$1.04M 0.01% 1270
2020
Q3
$15.5M Sell
65,400
-309,600
-83% -$69.5M 0.01% 1157
2020
Q2
$71.2M Buy
375,000
+360,000
+2,400% +$64.5M 0.05% 390
2020
Q1
$2.48M Sell
15,000
-28,800
-66% -$5.27M ﹤0.01% 1984
2019
Q4
$8.63M Hold
43,800
0.01% 1500
2019
Q3
$7.88M Buy
43,800
+600
+1% +$104K 0.01% 1450
2019
Q2
$7.55M Buy
43,200
+40,200
+1,340% +$6.89M 0.01% 1484
2019
Q1
$571K Buy
+3,000
New +$533K ﹤0.01% 3253

Other funds holding ISRG

Credit Suisse's ISRG Position: Q1 2024 in Review

Credit Suisse reduced its Intuitive Surgical (ISRG) stake by 16% in Q1 2024, selling an estimated $52.4M and leaving 747,649 shares worth $298M. The position accounts for 0.29% of the portfolio, ranked #61.

Credit Suisse first reported a position in ISRG in Q2 2013 and has held it in 44 quarters since. The position peaked at $482M in Q3 2021. 1,742 funds tracked by Wall St. Rank hold ISRG as of Q1 2024.

  • Credit Suisse held 747,649 shares of Intuitive Surgical worth $298M as of Q1 2024.
  • Credit Suisse sold 138,689 Intuitive Surgical shares in Q1 2024, an estimated $52.4M.
  • Intuitive Surgical made up 0.29% of Credit Suisse's portfolio in Q1 2024, its #61 holding.
  • Credit Suisse first reported a position in Intuitive Surgical in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Intuitive Surgical position peaked at $482M in Q3 2021.
  • 1,742 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.